MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

There is an increasing awareness that sex is a major determinant of the incidence,
aetiology, and clinical presentation of arrhythmias, and that there are sex differences in …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is associated
with a high risk of cardiovascular morbidity and death as well as with social, psychological …

METHODS: Protocol and registration This review was prospectively registered in the
Prospero International Prospective Register of Systematic Reviews (2018 ID …

Cardiovascular diseases (CVD) have a lower prevalence in women than men; although, a
higher mortality rate and a poorer prognosis are more common in women. However, there is …

Sex-specific differences in the epidemiology, pathophysiology, clinical presentation, clinical
treatment, and clinical outcomes of atrial fibrillation (AF), sustained ventricular arrhythmias …

There is a growing appreciation for differences in epidemiology, treatment, and outcomes of
cardiovascular conditions by sex. Historically, cardiovascular clinical trials have under …

Atrial fibrillation (AF) is a chronic progressive disease characterized by exacerbations and
remissions. It remains the most common sustained arrhythmia seen in clinical practice, and …